English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia

Wessely, R., Hengst, L., Jaschke, B., Wegener, F., Richter, T., Lupetti, R., et al. (2003). A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. Human Molecular Genetics, 12(2), 177-187.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Hum. Mol. Genet.

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Wessely, R., Author
Hengst, L.1, Author              
Jaschke, B., Author
Wegener, F., Author
Richter, T., Author
Lupetti, R.2, Author              
Paschalidis, M., Author
Schomig, A., Author
Brandl, R., Author
Neumann, F. J., Author
Affiliations:
1Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565145              
2External Organizations, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: Neointima formation, the leading cause of restenosis after catheter angioplasty, is a paradigm for vascular proliferative responses. Neointima formation is self-limiting after a variable degree of tissue growth, causing significant renarrowing in a substantial number of patients. To investigate the mechanisms that limit neointima formation we studied the role of the transcription factor IRF-1, which is a regulator of interferons and a tumor suppressor. We demonstrate that IRF-1 is highly regulated in human vascular lesions and exhibits a growth inhibitory function in coronary artery smooth muscle cells (CASMC). IRF-1 deficient mice display a high grade of susceptibility towards neointima formation following vessel injury. IRF-1 leads to G(1) cell cycle arrest in CASMC and induces the CDK inhibitor p21. In addition, IRF-1 induces NO production, which is known to attenuate endothelial dysfunction. Mitogen-mediated cellular migration is abrogated by IRF-1. In conclusion, IRF-1 displays pleiotropic anti- restenotic activities in vascular restenosis through transcriptional activation of several relevant mechanisms that limit neointima formation. These findings suggest an important role of this transcription factor as an endogenous inhibitor of neointimal growth following vessel injury and it is likely that IRF-1 regulation also plays a role in the pathophysiology of primary atherosclerosis. In addition, IRF-1 may be an interesting target for interventions to prevent neointimal hyperplasia.

Details

show
hide
Language(s): eng - English
 Dates: 2003-01-15
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 35283
ISI: 000180464200009
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Human Molecular Genetics
  Alternative Title : Hum. Mol. Genet.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 12 (2) Sequence Number: - Start / End Page: 177 - 187 Identifier: ISSN: 0964-6906